Working… Menu

Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS (CHANGE-MS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02782858
Recruitment Status : Completed
First Posted : May 25, 2016
Last Update Posted : October 20, 2020
Les Laboratoires Servier (LLS)
Institut de Recherches Internationales Servier
Worldwide Clinical Trials
Information provided by (Responsible Party):
GeNeuro SA

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2017
Actual Study Completion Date : December 2017